Skip to main content
# Title Department Research Year
211 Editorial: Advances in metabolism and chemodiversity - focus - plant enzymes 2023
212 Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3-(2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFRWT/EGFRT790M inhibitors Department of Pharmaceutical Organic Chemistry 2023
213 Convenient electrochemical and fluorometric dual-mode estimation of diosmin using carbon dots doped with nitrogen derived from chicken feet biowaste 2023
214 Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive Department of Pharmacology 2023
215 Anatase titanium oxide nanoparticles and multi-walled carbon nanotubes-modified carbon paste electrode for simultaneous determination of avanafil and doxorubicin in plasma samples 2023
216 The design, synthesis, biological evaluation, and molecular docking of new 5-aminosalicylamide-4-thiazolinone hybrids as anticancer agents Department of Pharmaceutical Organic Chemistry 2023
217 Combined Experimental/Computational Aspects for the Molecular Interaction of Empagliflozin with Bovine Serum Albumin: Quantification, and Application to Human Plasma Department of Pharmaceutical Analytical Chemistry 2023
218 Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl) Quinolin-2(1H)-Ones as Multi-Target Inhibitors Department of Pharmaceutical Organic Chemistry 2023
219 Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections 2023
220 Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action Department of Pharmaceutical Organic Chemistry 2023